Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.310
-0.050 (-3.68%)
Jan 10, 2025, 12:24 PM EST - Market open
RANI Stock Forecast
RANI's stock price has decreased by -54.36% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for RANI stock have an average target of 11.8, with a low estimate of 9.00 and a high estimate of 17. The average target predicts an increase of 800.76% from the current stock price of 1.31.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
The average analyst rating for RANI stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +587.02% | Nov 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +587.02% | Oct 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $9 | Strong Buy | Maintains | $13 → $9 | +587.02% | Aug 16, 2024 |
Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +1,197.71% | Aug 2, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +892.37% | Jun 25, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.02
from -1.33
EPS Next Year
-0.99
from -1.02
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | 45.6M | |||
Avg | n/a | n/a | 8.9M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.01 | -0.62 | -0.51 | |||
Avg | -1.02 | -0.99 | -0.72 | |||
Low | -1.04 | -1.59 | -1.01 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.